In lung cancer, Foxp3+ Tregs, which suppress auto-reactive T cells to maintain immunological self-tolerance and inhibit autoimmunity, are associated with advanced tumor growth and poor prognosis (137–139). Here, FOXP3 is linked to neoplasm.